Company intelligence / Profile preview
Biopharma Plasma
Kyiv, Kyiv, Ukrainebiopharma-plasma.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Biopharma Plasma is a leading Ukrainian pharmaceutical manufacturer specializing in human blood plasma-derived medicines. The company operates the only large-scale GMP-certified plasma fractionation plant in Ukraine and Eastern Europe, with capacity to process up to one million liters of plasma per year. Its key products include immunoglobulin, albumin, and the drug Bioven. During the COVID pandemic, it developed hyperimmune immunoglobulin from convalescent patients’ plasma and participated in international alliances for targeted therapies. Clinical trials are ongoing for some indications such as complex pneumonias including those caused by COVID.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Plasma-derived biologics (e.g., immunoglobulins, albumin)Recombinant drugsProbiotics based on spore-forming bacteria
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
CoVIg–19 Plasma Alliance with global leaders in plasma therapeutics during the pandemic.Investment partnerships with Horizon Capital’s EEGF II Fund and Dutch development finance bank FMO.
Beyond the preview
Go deeper on Biopharma Plasma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biopharma Plasma.